Literature DB >> 20816742

Coumarin-suberoylanilide hydroxamic acid as a fluorescent probe for determining binding affinities and off-rates of histone deacetylase inhibitors.

Raushan K Singh1, Tanmay Mandal, Narayanaganesh Balasubramanian, Gregory Cook, D K Srivastava.   

Abstract

Histone deacetylases (HDACs) are intimately involved in epigenetic regulation and, thus, are one of the key therapeutic targets for cancer, and two HDAC inhibitors, namely suberoylanilide hydroxamic acid (SAHA) and romidepsin, have been recently approved for cancer treatment. Because the screening and detailed characterization of HDAC inhibitors has been time-consuming, we synthesized coumarin-SAHA (c-SAHA) as a fluorescent probe for determining the binding affinities (K(d)) and the dissociation off-rates (k(off)) of the enzyme-inhibitor complexes. The determination of the above parameters relies on the changes in the fluorescence emission intensity (λ(ex)=325 nm, λ(em)=400 nm) of c-SAHA due to its competitive binding against other HDAC inhibitors, and such determination neither requires employment of polarization accessories nor is dependent on the fluorescence energy transfer from the enzyme's tryptophan residues to the probe. Our highly sensitive and robust analytical protocol presented here is applicable to most of the HDAC isozymes, and it can be easily adopted in a high-throughput mode for screening the HDAC inhibitors as well as for quantitatively determining their K(d) and k(off) values.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816742      PMCID: PMC2980575          DOI: 10.1016/j.ab.2010.08.040

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  37 in total

Review 1.  Protein modules that manipulate histone tails for chromatin regulation.

Authors:  R Marmorstein
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

Review 2.  Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.

Authors:  Cliona Grant; Fahd Rahman; Richard Piekarz; Cody Peer; Robin Frye; Robert W Robey; Erin R Gardner; William D Figg; Susan E Bates
Journal:  Expert Rev Anticancer Ther       Date:  2010-07       Impact factor: 4.512

3.  Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.

Authors:  Ralph Mazitschek; Vishal Patel; Dyann F Wirth; Jon Clardy
Journal:  Bioorg Med Chem Lett       Date:  2008-04-07       Impact factor: 2.823

Review 4.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.

Authors:  Paul A Marks; Ronald Breslow
Journal:  Nat Biotechnol       Date:  2007-01       Impact factor: 54.908

Review 5.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 6.  Structure and activity of enzymes that remove histone modifications.

Authors:  Marc A Holbert; Ronen Marmorstein
Journal:  Curr Opin Struct Biol       Date:  2005-11-02       Impact factor: 6.809

7.  Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.

Authors:  Abir L Banerjee; Michael Swanson; Bidhan C Roy; Xiao Jia; Manas K Haldar; Sanku Mallik; D K Srivastava
Journal:  J Am Chem Soc       Date:  2004-09-08       Impact factor: 15.419

8.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

9.  Fluorescence displacement method for the determination of receptor-ligand binding constants.

Authors:  P Kuzmic; M L Moss; J L Kofron; D H Rich
Journal:  Anal Biochem       Date:  1992-08-15       Impact factor: 3.365

Review 10.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  12 in total

1.  Real-time monitoring of conformational transitions of single-molecule histone deacetylase 8 with nanocircuits.

Authors:  Seungyong You; James Froberg; Junru Yu; Manas Haldar; Abbas Sedigh; Sanku Mallik; D K Srivastava; Yongki Choi
Journal:  Chem Commun (Camb)       Date:  2017-03-16       Impact factor: 6.222

2.  Photoreactive "nanorulers" detect a novel conformation of full length HDAC3-SMRT complex in solution.

Authors:  Hazem Abdelkarim; Michael Brunsteiner; Raghupathi Neelarapu; He Bai; Antonett Madriaga; Richard B van Breemen; Sylvie Y Blond; Vadim Gaponenko; Pavel A Petukhov
Journal:  ACS Chem Biol       Date:  2013-10-02       Impact factor: 5.100

3.  Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group.

Authors:  Youxuan Li; Patrick M Woster
Journal:  Medchemcomm       Date:  2015-04-01       Impact factor: 3.597

4.  Histone deacetylase activators: N-acetylthioureas serve as highly potent and isozyme selective activators for human histone deacetylase-8 on a fluorescent substrate.

Authors:  Raushan K Singh; Tanmay Mandal; Narayanaganesh Balsubramanian; Tajae Viaene; Travis Leedahl; Nitesh Sule; Gregory Cook; D K Srivastava
Journal:  Bioorg Med Chem Lett       Date:  2011-08-04       Impact factor: 2.823

5.  Novel Coumarin Substituted Water Soluble Cyclophosphazenes as "Turn-Off" Type Fluorescence Chemosensors for Detection of Fe(3+) ions in Aqueous Media.

Authors:  Gönül Yenilmez Çiftçi; Elif Şenkuytu; Mustafa Bulut; Mahmut Durmuş
Journal:  J Fluoresc       Date:  2015-09-29       Impact factor: 2.217

6.  Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a.

Authors:  Raushan K Singh; Naveena Lall; Travis S Leedahl; Abigail McGillivray; Tanmay Mandal; Manas Haldar; Sanku Mallik; Gregory Cook; D K Srivastava
Journal:  Biochemistry       Date:  2013-10-31       Impact factor: 3.162

7.  Lysine Deacetylases Exhibit Distinct Changes in Activity Profiles Due to Fluorophore Conjugation of Substrates.

Authors:  Tasha B Toro; Jenae R Bryant; Terry J Watt
Journal:  Biochemistry       Date:  2017-08-16       Impact factor: 3.162

8.  Kinetics and thermodynamics of metal-binding to histone deacetylase 8.

Authors:  Byungchul Kim; Amit S Pithadia; Carol A Fierke
Journal:  Protein Sci       Date:  2015-01-13       Impact factor: 6.725

9.  Mechanism of N-Acylthiourea-mediated activation of human histone deacetylase 8 (HDAC8) at molecular and cellular levels.

Authors:  Raushan K Singh; Kyongshin Cho; Satish K R Padi; Junru Yu; Manas Haldar; Tanmay Mandal; Changhui Yan; Gregory Cook; Bin Guo; Sanku Mallik; D K Srivastava
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

10.  Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme.

Authors:  Raushan K Singh; Takayoshi Suzuki; Tanmay Mandal; Narayanaganesh Balsubramanian; Manas Haldar; Dustin J Mueller; Jerrod A Strode; Gregory Cook; Sanku Mallik; D K Srivastava
Journal:  Biochemistry       Date:  2014-11-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.